Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Rowland

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δJonathan A Spencer, Ian R Baldwin, Nick Barton, et al.
The Journal of Biological Chemistry|December 15, 2005
Crystal structure of human cytochrome P450 2D6Paul Rowland, Frank E Blaney, Martin G Smyth, et al.
The Journal of Biological Chemistry|December 5, 2024
Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitorsThomas C Eadsforth, Leah S Torrie, Paul Rowland, et al.
Nature Communications|June 13, 2017
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenaseJonathan P Hutchinson, Paul Rowland, Mark R D Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2009
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituentNicolas Charrier, Brian Clarke, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296Brian Clarke, Leanne Cutler, Emmanuel Demont, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2006
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3Richard M Angell, Francis L Atkinson, Murray J Brown, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δJonathan A Spencer, Ian R Baldwin, Nick Barton, et al.
The Journal of Biological Chemistry|December 15, 2005
Crystal structure of human cytochrome P450 2D6Paul Rowland, Frank E Blaney, Martin G Smyth, et al.
The Journal of Biological Chemistry|December 5, 2024
Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitorsThomas C Eadsforth, Leah S Torrie, Paul Rowland, et al.
Nature Communications|June 13, 2017
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenaseJonathan P Hutchinson, Paul Rowland, Mark R D Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2009
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituentNicolas Charrier, Brian Clarke, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296Brian Clarke, Leanne Cutler, Emmanuel Demont, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2006
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3Richard M Angell, Francis L Atkinson, Murray J Brown, et al.
Pageof 5